These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16168709)

  • 1. SLE: challenges and candidates in human disease.
    Croker JA; Kimberly RP
    Trends Immunol; 2005 Nov; 26(11):580-6. PubMed ID: 16168709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A protective role for innate immunity in systemic lupus erythematosus.
    Carroll MC
    Nat Rev Immunol; 2004 Oct; 4(10):825-31. PubMed ID: 15459673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus.
    Stypińska B; Paradowska-Gorycka A
    Int J Mol Sci; 2015 Oct; 16(10):24194-218. PubMed ID: 26473848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLE: translating lessons from model systems to human disease.
    Singh RR
    Trends Immunol; 2005 Nov; 26(11):572-9. PubMed ID: 16153890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage.
    Dai C; Deng Y; Quinlan A; Gaskin F; Tsao BP; Fu SM
    Curr Opin Immunol; 2014 Dec; 31():87-96. PubMed ID: 25458999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of viral infection and B cells as a linker between innate and adaptive immune response in systemic lupus erythematosus.
    Ghobadi MZ; Izadi S; Teymoori-Rad M; Farahmand M; Mozhgani SH; Labbaf N; Shokri F; Marashi SM
    Immunol Res; 2021 Apr; 69(2):196-204. PubMed ID: 33786699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic lupus erythematosus: from pathophysiology to treatment].
    Contin-Bordes C; Lazaro E; Pellegrin JL; Viallard JF; Moreau JF; Blanco P
    Rev Med Interne; 2009 Dec; 30(12 Suppl):H9-13. PubMed ID: 19995652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of systemic lupus erythematosus].
    Alexander T; Radbruch A; Hiepe F
    Z Rheumatol; 2015 Apr; 74(3):183-90. PubMed ID: 25854151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus.
    Catalina MD; Owen KA; Labonte AC; Grammer AC; Lipsky PE
    J Autoimmun; 2020 Jun; 110():102359. PubMed ID: 31806421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
    Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basophilic granulocytes and autoimmune diseases. Can basophilic granulocytes modulate B-cell functions in systemic lupus erythematosus?].
    Meyer-Bahlburg A; Dijkstra D
    Z Rheumatol; 2016 Apr; 75(3):245-52. PubMed ID: 26820721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fcγ receptor and systemic autoimmune disease].
    Amano H
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(1):1-7. PubMed ID: 21372507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of Fcgamma and complement receptors on B cells in systemic lupus erythematosus.
    Gergely P; Isaák A; Szekeres Z; Prechl J; Erdei A; Nagy ZB; Gergely J; Poór G
    Ann N Y Acad Sci; 2007 Jun; 1108():183-92. PubMed ID: 17893984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell biology: implications for treatment of systemic lupus erythematosus.
    Anolik JH
    Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three checkpoints in lupus development: central tolerance in adaptive immunity, peripheral amplification by innate immunity and end-organ inflammation.
    Kanta H; Mohan C
    Genes Immun; 2009 Jul; 10(5):390-6. PubMed ID: 19262576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel therapeutic possibilities in systemic lupus erythematosus].
    Bazsó A; Poór G; Gergely P; Kiss E
    Orv Hetil; 2010 May; 151(18):735-40. PubMed ID: 20410000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defensins in systemic lupus erythematosus.
    Froy O; Sthoeger ZM
    Ann N Y Acad Sci; 2009 Sep; 1173():365-9. PubMed ID: 19758174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus.
    Niederer HA; Clatworthy MR; Willcocks LC; Smith KG
    Ann N Y Acad Sci; 2010 Jan; 1183():69-88. PubMed ID: 20146709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease.
    Fairhurst AM; Wandstrat AE; Wakeland EK
    Adv Immunol; 2006; 92():1-69. PubMed ID: 17145301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.